WHO’s 2018 Global TB Report calls for an unprecedented mobilization of national and international commitments; First-ever United Nations High-Level Meeting on TB provides historic opportunity.

Médecins Sans Frontières to Johnson & Johnson: We need affordable and sustainable supply of bedaquiline.

The Political Declaration was made public following the conclusion of a second silence procedure period.

Join stakeholders under the umbrella of the Nairobi Strategy on TB and Human Rights in demanding more from the UN High-Level Meeting on TB by signing a petition.

Advocates request that the South African Health Products Regulatory Authority expedite registration of essential medicines for the treatment and prevention of TB in South Africa.

The WHO, Ministries of Health and Finance, donors, implementers, technical assistance providers, civil society, and communities must work together to ensure rapid implementation.

Major improvement in treatment outcomes and quality of life of patients with multidrug-resistant TB (MDR-TB) are expected.

Apply to be a member of the revamped World Health Organization (WHO) Civil Society Task Force on TB.

U.S.-based civil society stakeholders submit a letter to U.S. Ambassador to the United Nations, Nikki Haley, urging a diplomatic solution to the contentious provisions on access to medicines in the draft declaration of the UN High-Level Meeting on TB.

The European AIDS Treatment Group (EATG) calls on the EU governments to support South Africa and the G77 states and push back on the Trump administration’s attempts to remove access language from the declaration.